|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/755 | |
| A61K 38/37 |
| (11) | Number of the document | 2536753 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11701527.1 |
| Date of filing the European patent application | 2011-02-02 | |
| (97) | Date of publication of the European application | 2012-12-26 |
| (45) | Date of publication and mention of the grant of the patent | 2017-12-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/051438 |
| Date | 2011-02-02 |
| (87) | Number | WO 2011/101242 |
| Date | 2011-08-25 |
| (30) | Number | Date | Country code |
| 305608 P | 2010-02-18 | US | |
| 10153718 | 2010-02-16 | EP |
| (72) |
PESCHKE, Bernd, DK
KOFOD-HANSEN, Mikael, DK
BUCHARDT, Jens, DK
STENNICKE, Henning Ralf, DK
STERGAARD, Henrik, DK
KJALKE, Marianne, DK
OLSEN, Eva H. Norling, DK
HANSEN, Jens Jacob, DK
|
| (73) |
Novo Nordisk A/S,
Novo Allé, 2880 Bagsvęrd,
DK
|
| (54) | FACTOR VIII MOLECULES WITH REDUCED VWF BINDING |
| FACTOR VIII MOLECULES WITH REDUCED VWF BINDING |